Home > Publications database > A Role of Non-Selective Beta-Blockers in Preventing Liver Decompensation in Patients with Hepatocellular Carcinoma Undergoing Systemic Therapy. > print

001     304466
005     20250909114905.0
024 7 _ |a 10.1016/j.jhep.2025.08.033
|2 doi
024 7 _ |a pmid:40912583
|2 pmid
024 7 _ |a 0168-8278
|2 ISSN
024 7 _ |a 1600-0641
|2 ISSN
037 _ _ |a DKFZ-2025-01859
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Allaire, Manon
|b 0
245 _ _ |a A Role of Non-Selective Beta-Blockers in Preventing Liver Decompensation in Patients with Hepatocellular Carcinoma Undergoing Systemic Therapy.
260 _ _ |a Amsterdam [u.a.]
|c 2025
|b Elsevier Science
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1757409387_22480
|2 PUB:(DE-HGF)
|x Letter
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a epub
536 _ _ |a 899 - ohne Topic (POF4-899)
|0 G:(DE-HGF)POF4-899
|c POF4-899
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a ascites
|2 Other
650 _ 7 |a clinically significant portal hypertension
|2 Other
650 _ 7 |a hepatocellular carcinoma
|2 Other
650 _ 7 |a liver decompensation
|2 Other
650 _ 7 |a non-selective beta-blocker
|2 Other
650 _ 7 |a portal hypertension
|2 Other
650 _ 7 |a varices
|2 Other
700 1 _ |a Meneghetti, Asier Rabasco
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Mouri, Sarah
|b 2
700 1 _ |a Kather, Jakob Nikolas
|0 P:(DE-He78)761f5d0f73e0d8f170394b29448a9e8d
|b 3
|u dkfz
700 1 _ |a Thabut, Dominique
|b 4
773 _ _ |a 10.1016/j.jhep.2025.08.033
|g p. S0168827825024699
|0 PERI:(DE-600)2027112-8
|p nn
|t Journal of hepatology
|v nn
|y 2025
|x 0168-8278
909 C O |o oai:inrepo02.dkfz.de:304466
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)761f5d0f73e0d8f170394b29448a9e8d
913 1 _ |a DE-HGF
|b Programmungebundene Forschung
|l ohne Programm
|1 G:(DE-HGF)POF4-890
|0 G:(DE-HGF)POF4-899
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-800
|4 G:(DE-HGF)POF
|v ohne Topic
|x 0
914 1 _ |y 2025
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2024-12-28
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2024-12-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2024-12-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2024-12-28
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-28
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J HEPATOL : 2022
|d 2024-12-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2024-12-28
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2024-12-28
915 _ _ |a IF >= 25
|0 StatID:(DE-HGF)9925
|2 StatID
|b J HEPATOL : 2022
|d 2024-12-28
920 1 _ |0 I:(DE-He78)DD01-20160331
|k DD01
|l DKTK Koordinierungsstelle Dresden
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)DD01-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21